TG Therapeutics, Inc. has announced a conference call scheduled for May 5, 2025, at 8:30 AM ET to discuss its first quarter financial results and provide a business outlook for the remainder of 2025.

NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX), today announced that a conference call will be held tomorrow, Wednesday, May 1, 2024, at 8:30 AM ET to discuss results for ...

A group of more than a dozen Republican lawmakers is urging a collegiate athletic conference to ban transgender women from competition after it was reported that a trans student competed on the ...

Gender Odyssey, Seattle’s annual transgender conference, is in full swing with thousands of therapists, families, and advocates coming together in what is predicted to be the largest of the yearly ...

Republican leaders from Congress expressed "serious concern" with the Mountain West Conference about transgender women participating in women's sports. Thirteen officials signed a letter to Mountain ...

Combination of TGR-1202 (umbralisib) plus ibrutinib appears well tolerated with no Grade 3/4 transaminitis, pneumonitis, diarrhea, or colitis observed, with longest patients on study 29.5+ months 94% ...

NEW YORK, Nov. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the 8th ...

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the ...

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday, November 3, 2025, at 8:30 AM ET to discuss results for ...